The US Department of Defence has awarded a coalition of researchers – made up of the Prostate Cancer Clinical Research Unit of the Spanish National Cancer Research Center (CNIO), the Prostate Cancer Translational Research Group of the Vall d'Hebron Institute of Oncology (VHIO) and the Genetics and Solid Tumors Laboratory of the University of Washington – the $2 million ‘Impact Award’ to fund a three year project intended to explore new therapeutic options in the fight against advanced prostate cancer.
Original Article: Prostate cancer researchers win $2m to explore carboplatin therapy